Research Advances of EGFR-TP53 Co-mutation in Advanced Non-small Cell Lung Cancer

Research Advances of EGFR-TP53 Co-mutation in Advanced Non-small Cell Lung Cancer

With the rapid development and wide application of next generation sequencing (NGS) technology, a series of researches have revealed that concurrent genetic alterations play an important role in the response and resistance of epidermal growth factor receptor (EGFR)-mutant NSCLC to EGFR-tyrosine kina...

Full description

Bibliographic Details
Main Authors:	Rong WANG, Sisi PAN, Xia SONG
Format:	Article
Language:	zho
Published:	Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2022-03-01
Series:	Chinese Journal of Lung Cancer
Subjects:	lung neoplasms tp53 epidermal growth factor receptor co-mutation therapy
Online Access:	http://dx.doi.org/10.3779/j.issn.1009-3419.2022.101.06

Similar Items

Concurrent TP53 mutations predict poor outcomes of EGFR-TKI treatments in Chinese patients with advanced NSCLC
by: Hou H, et al.
Published: (2019-06-01)

Optimal therapy for concomitant EGFR and TP53 mutated non-small cell lung cancer: a real-world study
by: Haiyan Sun, et al.
Published: (2023-03-01)

EGFR Gene Mutation Statuses in Advanced Non-small Cell Lung Cancer Patients and Their Influence on Effect of Gefitinib
by: Wei ZHONG, et al.
Published: (2012-09-01)

Concomitant TP53 mutation in early-stage resected EGFR-mutated non-small cell lung cancer: a narrative approach in a genetically admixed Brazilian cohort
by: J. Machado-Rugolo, et al.
Published: (2023-04-01)

TP53 mutations in circulating tumor DNA in advanced epidermal growth factor receptor-mutant lung adenocarcinoma patients treated with gefitinib
by: Ruofei Yu, et al.
Published: (2021-09-01)

Progress of Immunotherapy in EGFR-mutated Advanced Non-small Cell Lung Cancer
by: Yaoyao LIU, et al.
Published: (2023-12-01)

Concomitant <i>TP53</i> Mutation Confers Worse Prognosis in <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer Patients Treated with TKIs
by: Matteo Canale, et al.
Published: (2020-04-01)

The prognosis of TP53 and EGFR co-mutation in patients with advanced lung adenocarcinoma and intracranial metastasis treated with EGFR-TKIs
by: Weiguo Gu, et al.
Published: (2024-02-01)

Modified Restriction Enzyme-based Detection of EGFR Mutations in Lung Cancer
by: Fan YANG, et al.
Published: (2011-08-01)

Differences in genetics and microenvironment of lung adenocarcinoma patients with or without TP53 mutation
by: Dejun Zeng, et al.
Published: (2021-10-01)

Analysis of the Efficacy of Immunotherapy on the Posterior Lines  of Advanced EGFR Mutant Patients with Non-small cell Lung Cancer
by: Li MA, et al.
Published: (2021-05-01)

Lung adenocarcinomas with isolated TP53 mutation: A comprehensive clinical, cytopathologic and molecular characterization
by: Rachelle P. Mendoza, et al.
Published: (2024-01-01)

Quantitative Analysis of TP53-Related Lung Cancer Based on Radiomics
by: Qiao H, et al.
Published: (2022-12-01)

Advances in Treatment of Non-small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations
by: Xue YANG, et al.
Published: (2022-05-01)

The Relationship between EGFR Mutations and Response and Prognosis of Tyrosine Kinase Inhibitors in Advanced Non-small-cell Lung Cancer
by: Xuebing LI, et al.
Published: (2008-04-01)

The Role of <i>TP53</i> Mutations in <i>EGFR</i>-Mutated Non-Small-Cell Lung Cancer: Clinical Significance and Implications for Therapy
by: Matteo Canale, et al.
Published: (2022-02-01)

Efficacy of EGFR-TKI Plus Chemotherapy or Monotherapy as First-Line Treatment for Advanced EGFR-Mutant Lung Adenocarcinoma Patients With Co-Mutations
by: Zhengyu Yang, et al.
Published: (2021-08-01)

TP53 Mutation Mapping in Advanced Non-Small Cell Lung Cancer: A Real-World Retrospective Cohort Study
by: Fang Hao, et al.
Published: (2022-10-01)

Studies and Progress of EGFR exon 20 Insertion Mutation in Non-small Cell Lung Cancer
by: Wensheng ZHOU, et al.
Published: (2020-02-01)

Detection and Analysis of EGFR and KRAS Mutation with Lung Adenocarcinoma
by: Hui ZHANG, et al.
Published: (2015-11-01)

TP53 Co-Mutations in Advanced EGFR-Mutated Non–Small Cell Lung Cancer: Prognosis and Therapeutic Strategy for Cancer Therapy
by: Surui Liu, et al.
Published: (2022-04-01)

TP53 Loss of Heterozygosity Induces De Novo SCLC Formation in EGFR-Mutated Lung Adenocarcinoma: A Case Report
by: Kei Kunimasa, MD, PhD, et al.
Published: (2022-05-01)

Mutation patterns and evolutionary action score of TP53 enable identification of a patient population with poor prognosis in advanced non‐small cell lung cancer
by: Wensheng Jiang, et al.
Published: (2023-03-01)

Influence of Immunohistochemistry Scoring Criteria in Detecting EGFR Mutations
by: Xin FENG, et al.
Published: (2015-12-01)

Efficacy and safety analyses of epidermal growth factor receptor tyrosine kinase inhibitors combined with chemotherapy in the treatment of advanced non–small-cell lung cancer with an EGFR/TP53 co-mutation
by: Kai Shang, et al.
Published: (2022-12-01)

Advances in Double Mutations of EGFR and ALK Gene in Non-small Cell Lung Cancer
by: Xin WANG, et al.
Published: (2018-09-01)

Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis
by: Kang Qin, et al.
Published: (2020-04-01)

Searching for a cut-off point for p53 immunohistochemistry as evidence of TP53 mutations
by: Ilay Caliskan, et al.
Published: (2024-03-01)

Advances in immunotherapy of advanced non-small cell lung cancer with EGFR mutation
by: HUANG Huayan, et al.
Published: (2023-05-01)

Research Progress of Targeted Therapy for EGFR Gene in Non-small Cell Lung Cancer
by: Hui ZHANG, et al.
Published: (2017-01-01)

Research Progress of Angiogenesis Inhibitors Plus EGFR-TKI in EGFR-mutated  Advanced Non-small Cell Lung Cancer
by: Bowen LI, et al.
Published: (2022-08-01)

Detection and Analysis of EGFR and KRAS Mutations  in the Patients with Lung Squamous Cell Carcinomas
by: Hui ZHANG, et al.
Published: (2015-10-01)

Interaction between the microbiome and TP53 in human lung cancer
by: K. Leigh Greathouse, et al.
Published: (2018-08-01)

Detection and Its Clinical Significance of EGFR Gene Mutation and Gene Amplification in 187 Patients with Non-small Cell Lung Cancer
by: Qinghua ZHOU, et al.
Published: (2009-12-01)

TP53 GENE MUTATIONS – FROM GUARDIAN OF THE GENOME TO ONCOGENE
by: Petar Babović, et al.
Published: (2010-03-01)

Detection and Evaluation of EGFR Mutation Status in Serum of Patients with Advanced Non-small Cell Lung Cancer Treated with EGFR-TKIs
by: Ling MA, et al.
Published: (2013-06-01)

Epidermal Growth Factor Receptor Mutations and Radiotherapy  in Non-small Cell Lung Cancer
by: Xing ZHONG, et al.
Published: (2013-03-01)

Chinese Expert Consensus on Non-small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations (2023 Edition)
by: Chinese Society of Clinical Oncology (CSCO) Non-small Cell Lung Cancer Committee
Published: (2023-05-01)

TP53 mutation spectrum in smokers and never smoking lung cancer patients
by: Ann Rita Halvorsen, et al.
Published: (2016-05-01)

A Novel TP53 Gene Mutation Sustains Non-Small Cell Lung Cancer through Mitophagy
by: Yuanli Wang, et al.
Published: (2022-11-01)